(Q77524720)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806100%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Are there potential non-lipid-lowering uses of statins? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806100%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

D C Wheeler

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806100%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806100%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806100%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806100%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806100%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

517-522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806100%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-199856040-00001

6 December 2019

exact match

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

12 December 2020

Regulation of the mevalonate pathway

1 reference

12 December 2020

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study

1 reference

12 December 2020

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

1 reference

12 December 2020

Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.

1 reference

12 December 2020

Effect of simvastatin on ejection fraction in cardiac transplant recipients

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program

1 reference

12 December 2020

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

12 December 2020

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

12 December 2020

Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia

1 reference

12 December 2020

Hyperlipidemia in solid organ transplantation.

1 reference

12 December 2020

Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies

1 reference

12 December 2020

Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group

1 reference

12 December 2020

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

1 reference

12 December 2020

Essential role for mevalonate synthesis in DNA replication

1 reference

12 December 2020

Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia

1 reference

12 December 2020

Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor

1 reference

12 December 2020

Is vascular smooth muscle cell proliferation beneficial?

1 reference

12 December 2020

Lovastatin inhibits proliferation of rat mesangial cells

1 reference

12 December 2020

Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty

1 reference

12 December 2020

HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits

1 reference

12 December 2020

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

12 December 2020

Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

1 reference

12 December 2020

The dual role of mevalonate in the cell cycle

1 reference

12 December 2020

Posttranslational modification of proteins by isoprenoids in mammalian cells

1 reference

12 December 2020

The L-arginine-nitric oxide pathway

1 reference

12 December 2020

Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lovastatin

1 reference

12 December 2020

p21ras is modified by a farnesyl isoprenoid

1 reference

12 December 2020

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

12 December 2020

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation

1 reference

12 December 2020

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium

1 reference

12 December 2020

Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N,N'-bis(2-chloroethyl)-N-nitrosourea and beta-interferon on human glioma cells.

1 reference

12 December 2020

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

1 reference

12 December 2020

Lipids--what is the evidence for their role in progressive renal disease?

1 reference

12 December 2020

Hypertension, hyperlipidemia, and renal damage.

1 reference

12 December 2020

Chemotaxis of the monocyte cell line U937: Dependence on cholesterol and early mevalonate pathway products

1 reference

12 December 2020

Statins do more than just lower cholesterol

1 reference

12 December 2020

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines.

1 reference

12 December 2020

Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease

1 reference

12 December 2020

Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group

1 reference

12 December 2020

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

12 December 2020

Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies

1 reference

12 December 2020

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

1 reference

12 December 2020